Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
2025 Standout
Works of Florian Huemer being referenced
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
2020
The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Florian Huemer | 310 | 125 | 75 | 111 | 45 | 481 | |
| Emi Noguchi | 326 | 193 | 55 | 110 | 61 | 560 | |
| Frédéric Forget | 241 | 162 | 64 | 104 | 35 | 489 | |
| Ewa Chmielowska | 245 | 127 | 114 | 106 | 42 | 455 | |
| Katrin Bankov | 176 | 110 | 80 | 122 | 36 | 441 | |
| Robert Alter | 253 | 195 | 43 | 124 | 29 | 446 | |
| Berna Bozkurt Duman | 190 | 77 | 61 | 92 | 53 | 423 | |
| Erika Tóth | 204 | 97 | 101 | 89 | 63 | 432 | |
| Antonio Rueda‐Domínguez | 244 | 103 | 136 | 102 | 56 | 560 | |
| Barbara Burroni | 216 | 106 | 103 | 73 | 35 | 426 | |
| Jindřich Kopecký | 216 | 161 | 39 | 102 | 49 | 450 |
All Works
Login with ORCID to disown or claim papers
Loading papers...